Alvotech hefur klíníska rannsókn á AVT05, fyrirhugaðri líftæknilyfjahliðstæðu við…
<!-- Name:DistributionId Value:1000808124 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:True -->…
Browsing Tag
AVT05
Alvotech Initiates Pharmacokinetic Study for AVT05, a Proposed Biosimilar for…
REYKJAVIK, Iceland, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for…